Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition.

Suzuki T, Tada Y, Gladson S, Nishimura R, Shimomura I, Karasawa S, Tatsumi K, West J
Respir Res. 2017 18 (1): 177

PMID: 29037205 · PMCID: PMC5644255 · DOI:10.1186/s12931-017-0660-4

MeSH Terms (13)

Adamantane Animals Dipeptidyl-Peptidase IV Inhibitors Epithelial-Mesenchymal Transition Lipopolysaccharides Lung Injury Male Mice Mice, Inbred C57BL Nitriles Pulmonary Fibrosis Pyrrolidines Vildagliptin

Connections (1)

This publication is referenced by other Labnodes entities:

Links